What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition

The 2020 release of the WHO Classification of Soft Tissue and Bone Tumors, 5th edition, contains several changes driven by new knowledge in the field. These include reclassification of some entities, refinement of risk classification systems, and the inclusion of novel disease processes, many of whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Erica Y., Mantilla, Jose G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2022
Materias:
Newsletter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682218/
https://www.ncbi.nlm.nih.gov/pubmed/36413981
http://dx.doi.org/10.4132/jptm.2022.10.18
_version_ 1784834801887346688
author Kao, Erica Y.
Mantilla, Jose G.
author_facet Kao, Erica Y.
Mantilla, Jose G.
author_sort Kao, Erica Y.
collection PubMed
description The 2020 release of the WHO Classification of Soft Tissue and Bone Tumors, 5th edition, contains several changes driven by new knowledge in the field. These include reclassification of some entities, refinement of risk classification systems, and the inclusion of novel disease processes, many of which are driven by recurrent gene fusions. The most notable changes are described here.
format Online
Article
Text
id pubmed-9682218
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Society of Pathologists and the Korean Society for Cytopathology
record_format MEDLINE/PubMed
spelling pubmed-96822182022-12-05 What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition Kao, Erica Y. Mantilla, Jose G. J Pathol Transl Med Newsletter The 2020 release of the WHO Classification of Soft Tissue and Bone Tumors, 5th edition, contains several changes driven by new knowledge in the field. These include reclassification of some entities, refinement of risk classification systems, and the inclusion of novel disease processes, many of which are driven by recurrent gene fusions. The most notable changes are described here. The Korean Society of Pathologists and the Korean Society for Cytopathology 2022-11 2022-11-15 /pmc/articles/PMC9682218/ /pubmed/36413981 http://dx.doi.org/10.4132/jptm.2022.10.18 Text en © 2022 The Korean Society of Pathologists/The Korean Society for Cytopathology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Newsletter
Kao, Erica Y.
Mantilla, Jose G.
What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition
title What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition
title_full What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition
title_fullStr What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition
title_full_unstemmed What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition
title_short What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition
title_sort what’s new in soft tissue and bone pathology 2022–updates from the who classification 5th edition
topic Newsletter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682218/
https://www.ncbi.nlm.nih.gov/pubmed/36413981
http://dx.doi.org/10.4132/jptm.2022.10.18
work_keys_str_mv AT kaoericay whatsnewinsofttissueandbonepathology2022updatesfromthewhoclassification5thedition
AT mantillajoseg whatsnewinsofttissueandbonepathology2022updatesfromthewhoclassification5thedition

Ejemplares similares